Email UpdatesProposed Guidance for Toxicology Testing of Pregnant Patients
This guidance provides recommendations for screening pregnant patients for substance use disorder (SUD) to enhance the well-being of the maternalfetal dyad.
Clinical Guidelines
Offer evidence-based recommendations for clinicians about the care of patients.
Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use
This guideline updates the state of the science on pain research, care, and education with a particular focus on informing the Food and Drug Administration's (FDA's) development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Framing Opioid Prescribing Guidelines for Acute Pain
This guideline develops a framework to evaluate existing clinical practice guidelines for prescribing opioids for acute pain indications and recommends indications for which new evidence-based guidelines should be developed.
Polysubstance Use During Pregnancy
The official CDC page on research pertaining to polysubstance use during pregnancy, suggesting ways to help reduce substance exposure during pregnancy and improve the health of women and their children.
Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain
This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.
Practice Guideline for the Treatment of Patients with Substance Use Disorders: Second Edition
A Practice Guideline which includes treatment recommendations for patients with substance use disorders, as well as background information and a review of available evidence.
MAT Resources for FQHC Providers
This web page includes resources and documents to support providers in Federally Qualified Health Centers (FQHC) with implementing medications for substance use treatment. It includes sample workflows and templates, patient treatment agreements, clinical tools, procedures, and policies.
Supporting People with Addiction During COVID-19: A Webinar Series
A new webinar series from the National Academy of Medicine (NAM) and the American Society of Addiction Medicine (ASAM) providing insight and targeted guidance on how to ensure that people with addiction are cared for and protected during the COVID-19 public health crisis.
Behavioral Health Integration - Substance Use Disorder How-To Guide
This “how-to” guide provides physician practices and health systems with practical strategies, actionable steps and evidence-based resources for identifying and addressing unhealthy substance use or misuse in their patients.
The Changing Landscape of Alcohol Use Disorder and Problem Drinking in the USA: Implications for Primary Care
Provides primary care providers with information about the changing landscape of alcohol use disorder and other alcohol-related problems and how best to address problematic alcohol use